Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience ...
May 28, 2025
0
0
Every day, nearly 100 children present to Australian emergency departments with suspected medicine poisoning. It's a startling statistic, but a reality that could be avoided, according to new research from the University ...
May 28, 2025
0
0
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of age ...
May 28, 2025
0
0
Maintenance therapy with lurbinectedin (lurbi) and atezolizumab (atezo) helps some patients with extensive-stage small cell lung cancer (ES-SCLC) live longer versus maintenance therapy with atezolizumab alone, according to ...
May 27, 2025
0
0
A new study from UNC School of Medicine researchers, published this week in Blood, provides fresh insight into how the body forms and dissolves blood clots—and may help reshape how doctors treat patients at risk of bleeding.
May 26, 2025
0
2
The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).
May 26, 2025
0
4
The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to a five-year follow-up ...
May 23, 2025
0
3
For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the ...
May 22, 2025
0
0
A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The combined therapy works by preventing ...
May 22, 2025
0
0
A new study from researchers at Aarhus University and Aarhus University Hospital found no increased risk of neurodevelopmental disorders in children whose fathers were treated with valproate during spermatogenesis. The results ...
May 22, 2025
0
0
